hexamethonium has been researched along with quisqualic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, JL; Hong, Y | 1 |
| Bijak, M; Jarolimek, W; Misgeld, U | 1 |
| Kanfer, JN; Singh, IN; Sitar, DS; Sorrentino, G | 1 |
3 other study(ies) available for hexamethonium and quisqualic acid
| Article | Year |
|---|---|
Intrathecal administration of non-NMDA receptor agonists increases arterial pressure and heart rate in the rat.
Topics: Animals; Blood Pressure; Carbachol; Ganglia, Autonomic; Ganglionic Blockers; Glutamates; Glutamic Acid; Heart Rate; Hexamethonium; Hexamethonium Compounds; Injections, Spinal; Kainic Acid; Kynurenic Acid; Male; N-Methylaspartate; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission | 1992 |
Effects of antagonists on quisqualate and nicotinic receptor-mediated currents of midbrain neurones in culture.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; Animals; Cells, Cultured; Hexamethonium; Mesencephalon; Nicotinic Antagonists; Picrotoxin; Quisqualic Acid; Rats; Receptors, AMPA; Synapses | 1991 |
(-)Nicotine inhibits the activations of phospholipases A2 and D by amyloid beta peptide.
Topics: Acetophenones; Amyloid beta-Peptides; Arachidonic Acids; Aristolochic Acids; Brain; Brain Chemistry; Cells, Cultured; Cotinine; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Hexamethonium; Kainic Acid; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phenanthrenes; Phospholipase D; Phospholipases A; Phospholipases A2; Quisqualic Acid; Tubocurarine; Type C Phospholipases | 1998 |